Pharma & Life Sciences
Leveraging Innovation for Better Health:
Advancing Drug Discovery and Outcomes in the Digital Age
Sunday, October 8, 11:30 am - 1:50 pm PDT
Location: Level 3, Room 325-327
(Networking Lunch: 11:30am - 12:00pm)
Hosted in collaboration with Fierce Pharma, this program will explore practical applications, challenges and benefits of digital technologies, including reducing drug development risk and costs, enhancing diversity and efficiency in clinical trials, revolutionizing treatment access and service delivery, and empowering patients on the journey towards better health.
12:00pm - 12:35pm
Groundbreaking Technologies Reshaping Healthcare
A thought-provoking exploration of the groundbreaking technologies transforming healthcare and impacting drug discovery, research and development. Delve into the power and potential of precision diagnostics, artificial intelligence/machine learning, natural language processing, deep learning, and more.
Explore how these technological advancements are augmenting our understanding of disease, addressing complex clinical research problems, enabling seamless data harmonization and optimization, and charting new horizons in personalized care.
Paige Minemyer, Senior Editor, Fierce Healthcare
Mike Montello, SVP, Research & Development, Digital & Tech, GSK
Mary Rozenman, PhD, Chief Financial Officer/Chief Business Officer, insitro
Alex Snyder, MD, Executive Vice President, Research & Development, Generate Biomedicines
12:35pm - 1:10pm
The Ins and Outs of Implementing a Digital Strategy
Aimed at understanding the ins and outs of strategic implementation and expansion of digital technologies within the healthcare landscape. Explore the potential of these technologies to diminish drug development risks, reduce operational costs, enhance the safety and efficiency of clinical trials, and broaden the diversity of trial participants.
Learn about the practical aspects, hurdles, and benefits of establishing a robust digital strategy, fostering external partnerships, and improving technological capabilities to enable better health and treatment outcomes for patients.
Heather Landi, Senior Editor, Health Tech, Fierce Healthcare
Ashwin Athri, Head of Innovation, Precision Medicine Group.
Okan Ekinci, MD, MBA, Global Head of Innovation, Roche Information Solutions
Silvia Lopez-Lastra, PhD, Director of Biomedical Operations, Owkin
1:10pm - 1:45pm
Real World Opportunities:
Actualizing Digital Advances for Better Care
Going beyond the hype to look at the real-world application of advanced technologies and digital strategies for improving patient care. Explore how the continuous gathering of data, coupled with real-time patient engagement offers unprecedented opportunities – not only for translational research but also for delivering more precise, predictive insights and treatment options for patients.
Hear how digital technologies are improving clinical trial recruitment, patient diversity and retention and revolutionizing treatment access, service delivery, and personalized chronic care management.
Ayla Ellison, Editor-in-Chief, Healthcare and Life Sciences, Fierce Healthcare
Sarah Ernst, Head of Clinical Innovation & Strategy Implementation, Sanofi
Dorothy Gemmel, Chief Commercial Officer, GoodRX
Hannes Toivanen, PhD, Lead, Global Digital Ecosystem Engagement, Product & Experience Innovation, Takeda